Diagnostic utility of BRCA1-associated protein 1 (BAP1), Programmed Cell Death4 (PCD4) and Epithelial membrane antigen (EMA) expression in differentiation of malignant mesotheliom

The Significance of BRCA-associated Protein (BAP1) and Calretinin Expression in Malignant Pleural Mesothelioma and Non-small Cell Lung Carcinoma: An Immunohistochemical Study

Comparative study of BAP1 and CD147 expression in the diagnosis of malignant mesothelioma

Diagnostic Utility of BRCA1-Associated Protein 1 (BAP1) in Distinguishing Reactive and Neoplastic Mesothelial Proliferation

THE CORRELATION OF THE BRCA-IRIS GENE EXPRESSION AND BIOMARKER GENES IN BREAST CANCER PATIENTS: CORRELATION WITH TUMOR PROGRESSION AND RESPONSE TO TREATMENT

Cytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression

The Predictive Role of Cell Cycle Marker Tumor Protein 53 (TP53) in the Pathophysiology and Biological Behavior of Urinary Bladder Cancer

CLINICOPATHOLOGIC STUDY OF BASAL CELL CARCINOMA: A SINGLE-CENTRE RETROSPECTIVE STUDY

Clinicopathological Impact of CPA4, UHRF1, Glypican-1, and CD90 Expression in Lung Adenocarcinoma and Epithelioid Malignant Mesothelioma

TACC3 as a Prognostic Marker in Breast Carcinoma, an Immunohistochemical study in Qena University Hospitals